Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serrapeptase after total knee arthroplasty
ChiCTR2500101817Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2025
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of serrapeptase in postoperative pain (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Lower limb swelling and Joint pain at rest and during movement. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
serrapeptase
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500101817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101817.